Insulet Total Non-Cash Items 2010-2024 | PODD

Insulet annual/quarterly total non-cash items history and growth rate from 2010 to 2024. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
  • Insulet total non-cash items for the quarter ending December 31, 2024 were $29M, a 77.69% decline year-over-year.
  • Insulet total non-cash items for the twelve months ending December 31, 2024 were $-0.013B, a 104.03% decline year-over-year.
  • Insulet annual total non-cash items for 2024 were $0.029B, a 77.69% decline from 2023.
  • Insulet annual total non-cash items for 2023 were $0.13B, a 11.21% increase from 2022.
  • Insulet annual total non-cash items for 2022 were $0.117B, a 34.58% decline from 2021.
Insulet Annual Total Non-Cash Items
(Millions of US $)
2024 $29
2023 $130
2022 $117
2021 $179
2020 $141
2019 $107
2018 $85
2017 $66
2016 $58
2015 $53
2014 $71
2013 $42
2012 $35
2011 $18
2010 $33
2009 $21
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.646B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.329B 27.30
Boston Scientific (BSX) United States $151.960B 38.05
Stryker (SYK) United States $141.576B 30.43
EssilorLuxottica (ESLOY) France $131.433B 0.00
Medtronic (MDT) Ireland $108.503B 15.84
Lonza Group Ag (LZAGY) Switzerland $51.360B 0.00
Haleon (HLN) United Kingdom $46.382B 26.36
ResMed (RMD) United States $34.859B 26.18
GE HealthCare Technologies (GEHC) United States $31.175B 15.16
Agilent Technologies (A) United States $30.637B 20.24
Terumo (TRUMY) Japan $28.678B 0.00
Koninklijke Philips (PHG) Netherlands $23.527B 16.80
Zimmer Biomet Holdings (ZBH) United States $20.336B 12.85
Baxter (BAX) United States $15.890B 11.43
Smith & Nephew SNATS (SNN) United Kingdom $11.790B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.119B 17.50
Bio-Rad Laboratories (BIO) United States $6.788B 23.50
Prestige Consumer Healthcare (PBH) United States $4.059B 19.37
Perrigo (PRGO) Ireland $3.496B 10.01
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.378B 28.78
Haemonetics (HAE) United States $3.214B 15.12
Envista Holdings (NVST) United States $2.745B 22.19
GN Store Nord (GNNDY) Denmark $2.260B 15.23
LeMaitre Vascular (LMAT) United States $2.092B 47.73
QuidelOrtho (QDEL) United States $1.928B 16.15
AtriCure (ATRC) United States $1.715B 0.00
Kestra Medical Technologies (KMTS) United States $1.258B 0.00
Green Thumb Industries (GTBIF) United States $1.250B 19.63
BioLife Solutions (BLFS) United States $1.174B 0.00
AdaptHealth (AHCO) United States $1.129B 10.87
Neogen (NEOG) United States $1.092B 13.97
InMode (INMD) Israel $1.003B 9.18
Phibro Animal Health (PAHC) United States $0.765B 11.73
Evolus (EOLS) United States $0.746B 0.00
Curaleaf Holdings (CURLF) Canada $0.596B 0.00
CeriBell (CBLL) United States $0.587B 0.00
Capricor Therapeutics (CAPR) United States $0.574B 0.00
Owens & Minor (OMI) United States $0.541B 4.61
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.526B 0.00
Tilray Brands (TLRY) Canada $0.493B 0.00
Surmodics (SRDX) United States $0.442B 0.00
Omeros (OMER) United States $0.419B 0.00
Cresco Labs (CRLBF) United States $0.414B 0.00
SNDL (SNDL) Canada $0.389B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.346B 15.02
Verano Holdings (VRNOF) United States $0.307B 0.00
Sanara MedTech (SMTI) United States $0.286B 0.00
Viemed Healthcare (VMD) United States $0.275B 24.82
ZimVie (ZIMV) United States $0.264B 15.78
Aurora Cannabis (ACB) Canada $0.261B 46.40
Cerus (CERS) United States $0.260B 0.00
Canopy Growth (CGC) Canada $0.256B 0.00
OraSure Technologies (OSUR) United States $0.237B 0.00
Quanterix (QTRX) United States $0.235B 0.00
Sanuwave Health (SNWV) United States $0.220B 0.00
High Tide (HITI) Canada $0.196B 0.00
Biote (BTMD) United States $0.194B 4.43
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.89
Brainsway (BWAY) Israel $0.168B 52.29
Organigram Global (OGI) Canada $0.144B 0.00
FitLife Brands (FTLF) United States $0.143B 17.99
Jin Medical (ZJYL) China $0.140B 0.00
Exagen (XGN) United States $0.123B 0.00
Agape ATP (ATPC) $0.121B 0.00
TerrAscend (TSNDF) Canada $0.108B 0.00
MacroGenics (MGNX) United States $0.101B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Veru (VERU) United States $0.081B 0.00
Fonar (FONR) United States $0.078B 10.86
Cytosorbents (CTSO) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.068B 0.00
Zynex (ZYXI) United States $0.067B 0.00
United Health Products (UEEC) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.038B 55.00
Safety Shot (SHOT) United States $0.037B 0.00
United-Guardian (UG) United States $0.036B 11.11
Apyx Medical (APYX) United States $0.036B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00